AMICUS THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AMICUS THERAPEUTICS, INC. (FOLD), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are FOLD insiders buying or selling?
AMICUS THERAPEUTICS, INC. insiders reported 23 open-market buys ($8.9M) and 253 sells ($64.7M) across 276 Form 4 filings — a net selling position of $55.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 5, 2026)
Insider sentiment
Net sellingNet insider flow of $55.8M in net selling.
Recent FOLD insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Bradley L Campbell | President and CEO | Sale | 22.5K | $14.35 | $322.8K |
| Jan 23, 2026 | Bradley L Campbell | President and CEO | Sale | 75.0K | $14.31 | $1.1M |
| Dec 23, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $14.17 | $363.4K |
| Dec 17, 2025 | Bradley L Campbell | President and CEO | Sale | 77.9K | $10.86 | $846.0K |
| Dec 17, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $11.00 | $282.1K |
| Dec 4, 2025 | Bradley L Campbell | President and CEO | Sale | 14.6K | $10.01 | $146.0K |
| Nov 27, 2025 | Jeff Castelli | Chief Development Officer | Sale | 76.2K | $10.16 | $773.7K |
| Nov 27, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $10.10 | $258.9K |
| Nov 27, 2025 | Bradley L Campbell | President and CEO | Sale | 14.6K | $10.04 | $146.5K |
| Nov 27, 2025 | Ellen Rosenberg | Chief Legal Officer | Sale | 95.6K | $10.02 | $958.5K |
| Nov 5, 2025 | David Michael Clark | Chief People Officer | Sale | 25.6K | $9.51 | $243.9K |
| Feb 22, 2025 | Bradley L Campbell | President and CEO | Sale | 400 | $10.00 | $4.0K |
| Dec 3, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.02 | $75.1K |
| Nov 7, 2024 | Bradley L Campbell | President and CEO | Sale | 7.9K | $12.50 | $98.8K |
| Nov 4, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $11.46 | $86.0K |
| Oct 4, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.60 | $79.5K |
| Sep 5, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $11.71 | $87.8K |
| Aug 6, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.34 | $77.5K |
| Jul 9, 2024 | Bradley L Campbell | President and CEO | Sale | 6.1K | $10.00 | $61.0K |
| Jul 3, 2024 | Bradley L Campbell | President and CEO | Sale | 1.4K | $10.00 | $14.0K |
| Jun 5, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.00 | $75.0K |
| May 3, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $10.07 | $75.5K |
| Apr 3, 2024 | Bradley L Campbell | President and CEO | Sale | 7.5K | $11.67 | $87.5K |
| Mar 15, 2024 | John F Crowley | Executive Chairman | Sale | 31.6K | $13.65 | $431.5K |
| Mar 6, 2024 | Margaret G Mcglynn | Director | Sale | 15.0K | $13.35 | $200.2K |
Showing the 25 most recent of 276 Form 4 filings for AMICUS THERAPEUTICS, INC..
Most active FOLD insiders
- John F Crowley102 filings
- Bradley L Campbell75 filings
- Burke W Whitman19 filings
- Jay Barth13 filings
- David Michael Clark11 filings
Ask anything about FOLD insider activity
Use Trabud's AI agent to query AMICUS THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me FOLD CEO purchases this year" or compare it against any other ticker.
Open the AI agentFOLD insider trading FAQ
Are AMICUS THERAPEUTICS, INC. insiders buying or selling?
Across 276 SEC Form 4 filings, AMICUS THERAPEUTICS, INC. (FOLD) insiders reported 23 open-market purchases totaling $8.9M and 253 sales totaling $64.7M. That is a net selling position of $55.8M.
How many insiders trade FOLD stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AMICUS THERAPEUTICS, INC.. The most recent filing was accepted on Mar 5, 2026.
Where does Trabud get FOLD insider trading data?
All FOLD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.